Home

Pfizer (PFE)

24.84
+0.36 (1.47%)
NYSE · Last Trade: Jun 12th, 6:26 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Explore the S&P500 index on Thursday and find out which stocks are the most active in today's session.chartmill.com
Stay informed about the most active stocks in the S&P500 index on Thursday's session. Discover the stocks that are generating the highest trading volume and driving market activity.
Via Chartmill · June 12, 2025
BioNTech To Acquire CureVac In All-Stock Deal Valued At $1.25B: Retail Sees Breakthrough In Cancer Treatmentstocktwits.com
Under the terms of the deal, each CureVac share will be exchanged for approximately $5.46 in BioNTech American depositary shares.
Via Stocktwits · June 12, 2025
Create a Portfolio of Passive Income: 3 High-Yielding Dividend Stocks That Pay More Than 5%fool.com
Via The Motley Fool · June 12, 2025
RFK Jr. Appoints Vaccine Critics To CDC Vaccine Panel After Firing Entire Advisory Committee: Reportbenzinga.com
Health Secretary Robert F. Kennedy Jr. named eight new members to the CDC's Advisory Committee on Immunization Practices.
Via Benzinga · June 12, 2025
5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Offfool.com
Steady growth and dividend increases over decades can make investors remarkably wealthy.
Via The Motley Fool · June 11, 2025
Insmed Catapults Into Breakout Territory On A 'Home Run' For Its Rival To United, Liquidiainvestors.com
Shares look likely to break out at the open after the biotech company unveiled promising results for a pulmonary arterial hypertension treatment.
Via Investor's Business Daily · June 10, 2025
2 Weight Loss Drug Stocks That Are Screaming Buys in Junefool.com
These companies own 97% of the weight loss drug market -- which could grow tenfold over the next decade -- and are developing next-generation offerings.
Via The Motley Fool · June 10, 2025
Robert Kennedy Jr Axes Entire CDC Vaccine Panel To 'Restore Public Trust' — Pfizer, Moderna, Other Biotech Stocks Drop In After-Hours Tradingbenzinga.com
A sweeping overhaul of the CDC's top vaccine advisory panel is ripping through the medical world, while rattling pharma and biotech stocks.
Via Benzinga · June 10, 2025
Vaccine Stocks Alert: Has RFK Jr.'s CDC Panel Shakeup Sent Retail Traders To The Sidelines?stocktwits.com
Kennedy said the Department of Health and Human Services would retire all 17 current members of the ACIP, citing what he called a "crisis of public trust."
Via Stocktwits · June 10, 2025
Vaccine Stocks Moderna, Pfizer Hit After A Surprise Blow From RFK Jr.investors.com
A CDC committee in charge of making vaccine recommendations was gutted Monday to make way for a new coalition.
Via Investor's Business Daily · June 9, 2025
Metsera Stock Climbs On Positive Results From Early Stage Trial For Investigational Weight-Loss Drug: Retail Chatter Explodesstocktwits.com
The company said that the drug, MET-233i, demonstrated up to 8.4% mean placebo-subtracted weight loss at day 36.
Via Stocktwits · June 9, 2025
These S&P500 stocks are the most active in today's sessionchartmill.com
Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest.
Via Chartmill · June 9, 2025
Pfizer CEO Reportedly Says Company Made No Drug Price Pledges In Meeting With Trump Administration: Retail Sentiment Improvesstocktwits.com
The meeting follows an executive order from President Trump last month, which directed drugmakers to lower medicine prices to the levels paid by other high-income countries.
Via Stocktwits · June 9, 2025
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yieldsbenzinga.com
Via Benzinga · June 9, 2025
3 Stocks With Mouthwatering Dividends You Can Buy Right Nowfool.com
Via The Motley Fool · June 8, 2025
Should You Buy Pfizer Stock Right Now?fool.com
Via The Motley Fool · June 7, 2025
Pfizer, Arvinas Partnered Breast Cancer Drug Cuts Progression Risk By 43% In Trial, Seeks FDA Approvalbenzinga.com
Arvinas and Pfizer submit NDA to FDA for vepdegestrant after Phase 3 data shows efficacy in ESR1-mutated ER+/HER2- breast cancer patients
Via Benzinga · June 6, 2025
RFK Jr. Champions 'Medical Freedom' While Curtailing Access, Say Public Health Expertsbenzinga.com
U.S. Health Secretary Robert F. Kennedy Jr. has championed "medical freedom" while simultaneously limiting access to COVID-19 vaccines and restricting food stamp purchases, creating what public health experts call a dichotomy in his approach to healthcare policy.
Via Benzinga · June 6, 2025
Better High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologisfool.com
Via The Motley Fool · June 5, 2025
Here Are All 6 Stocks I've Bought Through 5 Months of 2025fool.com
A volatile stock market represents an ideal opportunity for long-term investors to pounce.
Via The Motley Fool · June 5, 2025
S&P 500 Earnings Stun The Street In Q1 With Broad-Based Beats, Double-Digit Growthbenzinga.com
Nearly 80% of S&P 500 firms beat Q1 earnings forecasts. Profit growth hit 13.3%, led by tech and health care, says FactSet.
Via Benzinga · June 3, 2025
These 2 Dow Stocks Are Set to Soar in 2025 and Beyondfool.com
Apple and Cisco could generate surprising gains over the next few years.
Via The Motley Fool · June 3, 2025
3 Safe Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 11.35% -- That Make for No-Brainer Buys in Junefool.com
Three supercharged dividend stocks have the tools and intangibles to fatten investors' pocketbooks in June, and well beyond.
Via The Motley Fool · June 3, 2025
Why BioNTech Stock Soared Todayfool.com
Bristol Myers Squibb just agreed to shower BioNTech with cash.
Via The Motley Fool · June 2, 2025
Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Pfizer (NYSE:PFE)
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Pfizer (NYSE:PFE) and its peers.
Via StockStory · June 1, 2025